Akiko Tamura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Case Report of a Rapidly Progressive Indolent T-Cell Lymphoma of the Gastrointestinal Tract.
Journal: DEN open
Published: February 06, 2026
Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative Colitis.
Journal: Inflammatory intestinal diseases
Published: November 11, 2025
Stricture dynamics and prognosis during biologic therapy in ileal Crohn's disease: a real-world cohort.
Journal: Inflammatory bowel diseases
Published: October 17, 2025
Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis.
Journal: Digestion
Published: October 02, 2025
Efficacy and Rapid Response of Ustekinumab for Hospitalized Patients With Severe Ulcerative Colitis.
Efficacy and Rapid Response of Ustekinumab for Hospitalized Patients With Severe Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: August 13, 2025
Improved transfection methods for observation of cytoskeletal structures in primary cultured astrocytes.
Journal: Journal of cell science
Published: July 16, 2025
Newly Diagnosed Crohn's Disease After SARS-CoV-2 Infection.
Journal: Case reports in gastrointestinal medicine
Published: May 22, 2025
Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis Patients over and under 65 Years of Age: A Real-World Comparative Analysis.
Journal: Inflammatory intestinal diseases
Published: March 25, 2025
Real-World Data on the Effectiveness of Ustekinumab and Risankizumab for Crohn's Disease.
Journal: Inflammatory intestinal diseases
Published: March 10, 2025
Association of FDG-PET/CT findings with adequate tissue samples for gene panel testing in transbronchial lung biopsy and endobronchial ultrasound-guided transbronchial needle aspiration.
Journal: Respiratory investigation
Published: March 09, 2025
Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan.
Journal: Intestinal research
Published: November 14, 2024
Last Updated: 09/26/2026